Squamous cell carcinoma arising in a skin graft donor site following melanoma extirpation at a distant site: A case report and review of the literature
Abstract:s u m m a r yThe development of both squamous cell carcinoma (SCC) and keratoacanthoma (KA) in donor sites following split thickness skin graft harvest are rare complications reported in the literature. Management of such cases requires a precise distinction between keratoacanthoma and SCC and knowledge of the degree of differentiation. We describe the case of a 48-year-old male who developed a squamous cell carcinoma with features of KA within a donor site on his right thigh. This developed six weeks followin… Show more
“…In our review of the literature, we found a total of 16 documented cases. [5][6][7][8][9][10] Our case report represents a de novo occurrence of a well differentiated SCC at a skin graft donor site for reconstruction of chronically infected bilateral hip wounds. It can be inferred that our patient's chronic wounds were a factor for the development of SCC at the donor site.…”
Section: Discussionmentioning
confidence: 87%
“…Five of the previous case reports found SCC in skin graft donor sites in patients who were undergoing reconstruction with skin grafting for resected skin cancers, which indicates a potential relationship between the original cancer and the SCC arising at the donor site. [5][6][7][8][9] One case report demonstrated the implantation of SCC after using the same hollow bore needle for injection in both the area around the skin cancer and the donor site, indicating the cancer may have seeded into the donor site. 6 Other case reports describe patients who developed SCC at the skin graft donor sites who had undergone reconstruction after burns.…”
Introduction: Skin graft reconstruction is a common method of providing wound coverage. Rarely, skin grafting can be associated with the development of squamous cell carcinoma (SCC) in the graft donor site. Case Report: The patient is a 72-year old male with a 15-year history of bilateral hip wounds. He underwent a multitude of treatments previously with failed reconstructive efforts. After presenting to us, he underwent multiple debridements and eventual skin grafting. Within 4 weeks of the final skin graft, a mass developed at the skin graft donor site at the right thigh. Excisional biopsy returned a well differentiated keratinizing SCC. Discussion/Conclusion: This case demonstrates the acute presentation of SCC in a patient following a skin graft without known risk factors. The purpose of this unique case report is to highlight a very rare occurrence of SCC at a skin graft donor site.
“…In our review of the literature, we found a total of 16 documented cases. [5][6][7][8][9][10] Our case report represents a de novo occurrence of a well differentiated SCC at a skin graft donor site for reconstruction of chronically infected bilateral hip wounds. It can be inferred that our patient's chronic wounds were a factor for the development of SCC at the donor site.…”
Section: Discussionmentioning
confidence: 87%
“…Five of the previous case reports found SCC in skin graft donor sites in patients who were undergoing reconstruction with skin grafting for resected skin cancers, which indicates a potential relationship between the original cancer and the SCC arising at the donor site. [5][6][7][8][9] One case report demonstrated the implantation of SCC after using the same hollow bore needle for injection in both the area around the skin cancer and the donor site, indicating the cancer may have seeded into the donor site. 6 Other case reports describe patients who developed SCC at the skin graft donor sites who had undergone reconstruction after burns.…”
Introduction: Skin graft reconstruction is a common method of providing wound coverage. Rarely, skin grafting can be associated with the development of squamous cell carcinoma (SCC) in the graft donor site. Case Report: The patient is a 72-year old male with a 15-year history of bilateral hip wounds. He underwent a multitude of treatments previously with failed reconstructive efforts. After presenting to us, he underwent multiple debridements and eventual skin grafting. Within 4 weeks of the final skin graft, a mass developed at the skin graft donor site at the right thigh. Excisional biopsy returned a well differentiated keratinizing SCC. Discussion/Conclusion: This case demonstrates the acute presentation of SCC in a patient following a skin graft without known risk factors. The purpose of this unique case report is to highlight a very rare occurrence of SCC at a skin graft donor site.
“…La tasa estimada de recidiva local en los injertos de piel en el sitio de melanoma primario es del 1 al 8%, 10 por lo que se han considerado distintas maniobras preventivas para el desarrollo de melanoma en el sitio donante, variando desde exámenes dermatoscópicos rigurosos del área donante, detección de tirosina hidroxilasa (mRNA) mediante RT-PCR, biopsia linfática, inmunohistoquímica para antígeno S100, HMB-45 y p53. 11 Tenemos la teoría de que se crea una obstrucción de la función inmunológica en referencia a los inmunomarcadores, los que al encontrarse con una obstrucción, que en este caso específico podrían ser las secuelas cicatrízales de maduración, podrían obstruir o ralentizar el proceso en el que se detecta y ataca las células tumorales. También se han registrado casos en los que no sólo el sitio receptor es el afectado, también el sitio donante; en dichos casos se hace referencia al mecanismo de diseminación hematógena y de contaminación y esto se refuerza con la presencia de antecedentes de uso de agentes biológicos para el manejo de cáncer; dicho uso activa los oncogenes BRAF V600E y C-KIT, los cuales son bien conocidos como precursores importantes para el desarrollo de melanoma cutáneo.…”
Section: Discussionunclassified
“…También se han registrado casos en los que no sólo el sitio receptor es el afectado, también el sitio donante; en dichos casos se hace referencia al mecanismo de diseminación hematógena y de contaminación y esto se refuerza con la presencia de antecedentes de uso de agentes biológicos para el manejo de cáncer; dicho uso activa los oncogenes BRAF V600E y C-KIT, los cuales son bien conocidos como precursores importantes para el desarrollo de melanoma cutáneo. [9][10][11]…”
Desarrollo de un melanoma primario dentro de un injerto de espesor total de piel; reporte de un caso Development of a primary melanoma within a full-thickness skin graft; a case report
“…ESCC have been reported to arise at the sites of skin surgery, including the area affected by the primary tumor and split thickness skin graft (STSG) donor and recipient sites [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19]. The best therapeutic option for ESCC after surgery in our opinion is still a challenge.…”
Multiple eruptive cutaneous non-melanoma skin cancers(NMSCs) have been reported to arise at the sites of skin surgery, including the area affected by the primary tumour and split thickness skin graft(STSG) donor and recipient sites. The aim of this study is to make a critical revision of the literature, analysing the clinical, histological features and outcomes of eruptive NMSCs after cutaneous surgery. Up to August 2021, according to our systematic review of the literature, we have collected 18 published articles and a total of 33 patients, including our two cases. The results of this review highlight five red flags that clinicians should consider: (i) lower and upper limbs represent the cutaneous site with the highest risk, representing 82.35% of the cases in the literature; (ii) the median time to onset of eruptive NMSCs that is approximately 6 weeks; (iii) primary NMSCs were completely excised with free margins on histologic examination in all cases of the literature, and therefore the eruptive NMSCs reported could not be considered recurrences; (iv) any surgical technique involves a risk to promote eruptive NMSCs; (v) treatment of eruptive NMSCs includes surgery or combined surgical and medical treatment. However, eruptive NMSCs recurrences are a real medical challenge and have always been treated combining surgical and medical treatment, with complete resolution in about one third of patients. In conclusion, even though the pathogenesis remains unclear, this review highlights 5 red flags which could support clinicians in the diagnosis and management of eruptive of NMSCs after skin surgery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.